| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 77 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 71 |
| 2 | TACROLIMUS OINTMENT 0.1% | 71 |
| 3 | PREDNISONE | 66 |
| 4 | MYCOPHENOLATE MOFETIL | 43 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 43 |
| 6 | PREDNISOLONE | 43 |
| 7 | PREDNISOLONE ORAL | 43 |
| 8 | PREDNISOLONE ORAL SOLUTION | 43 |
| 9 | AZATHIOPRINE | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MOSUNETUZUMAB | 4 | 0.0036 |
| 1 | IMIPENEM AND CILASTATIN SODIUM | 3 | 0.0014 |
| 2 | MYCOPHENILIC ACID | 24 | 0.0011 |
| 3 | EPCORITAMAB-BYSP | 1 | 0.0007 |
| 4 | MYCOPHENOLIC ACID | 24 | 0.0007 |
| 5 | BARICITINIB | 2 | 0.0007 |
| 6 | TACROLIMUS OINTMENT 0.1% | 71 | 0.0006 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 71 | 0.0006 |
| 8 | ALEMTUZUMAB | 10 | 0.0005 |
| 9 | BASILIXIMAB | 6 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 24 | 0.0011 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 10 | 0.0005 |
| 2 | Oxazolidinone Antibacterial [EPC] | 12 | 0.0004 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 8 | 0.0004 |
| 4 | Sulfone [EPC] | 3 | 0.0003 |
| 5 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 6 | Purine Antimetabolite [EPC] | 24 | 0.0002 |
| 7 | Antimalarial [EPC] | 2 | 0.0002 |
| 8 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 9 | Penem Antibacterial [EPC] | 6 | 0.0002 |